Add to ORKGMeta-analyses of randomized and cohort cell therapy studies have reported that intracoronary or intramyocardial cell delivery was safe, and it provided 2 % to 8 % increases in global left ventricular (LV) ejection fraction (EF) in patients with acute myocardial infarction (AMI) or ischemic cardiomyopathy.1–4 Those meta-analyses were based on information from published articles and included different patient populations, follow-up times, and outcome measures, resulting in data heterogeneity because of inconsistent clinical definitions and parameters. I
Heart failure (HF) is one of the leading causes of death worldwide and has reached epidemic proporti...
International audienceAIMS: Intracoronary administration of autologous bone marrow cells (BMCs) lead...
AIMS: To investigate whether there are important sources of heterogeneity between the findings of di...
International audienceThe meta-Analysis of Cell-based CaRdiac study is the first prospectively decla...
ObjectivesWe aimed to perform a meta-analysis of clinical trials on intracoronary cell therapy after...
OBJECTIVES: We aimed to perform a meta-analysis of clinical trials on intracoronary cell therapy aft...
Context Numerous randomized controlled studies assessing intracoronary bone marrow cell therapy (BM...
Background-Several cell-based therapies for adjunctive treatment of acute myocardial infarction have...
Recent studies report that intracoronary administration of autologous bone marrow mononucleated cell...
Use of drug-eluting stents in patients with acute myocardial infarction (AMI) remains an "off label"...
Background Bone marrow-derived cell therapy has been used to treat acute myocardial...
International audienceAIMS: The objective of the present analysis was to systematically examine the ...
RATIONALE: Cardiac stem cells (CSC) therapy has been clinically introduced for cardiac repair after ...
Heart failure (HF) is one of the leading causes of death worldwide and has reached epidemic proporti...
International audienceAIMS: Intracoronary administration of autologous bone marrow cells (BMCs) lead...
AIMS: To investigate whether there are important sources of heterogeneity between the findings of di...
International audienceThe meta-Analysis of Cell-based CaRdiac study is the first prospectively decla...
ObjectivesWe aimed to perform a meta-analysis of clinical trials on intracoronary cell therapy after...
OBJECTIVES: We aimed to perform a meta-analysis of clinical trials on intracoronary cell therapy aft...
Context Numerous randomized controlled studies assessing intracoronary bone marrow cell therapy (BM...
Background-Several cell-based therapies for adjunctive treatment of acute myocardial infarction have...
Recent studies report that intracoronary administration of autologous bone marrow mononucleated cell...
Use of drug-eluting stents in patients with acute myocardial infarction (AMI) remains an "off label"...
Background Bone marrow-derived cell therapy has been used to treat acute myocardial...
International audienceAIMS: The objective of the present analysis was to systematically examine the ...
RATIONALE: Cardiac stem cells (CSC) therapy has been clinically introduced for cardiac repair after ...
Heart failure (HF) is one of the leading causes of death worldwide and has reached epidemic proporti...
International audienceAIMS: Intracoronary administration of autologous bone marrow cells (BMCs) lead...
AIMS: To investigate whether there are important sources of heterogeneity between the findings of di...